Subject(s)
Ascitic Fluid/microbiology , COVID-19/diagnosis , COVID-19/prevention & control , Colectomy , Patient Care Planning , SARS-CoV-2/isolation & purification , Aged , Colitis/surgery , Colonic Polyps/surgery , Cross Infection/prevention & control , Fatal Outcome , Female , Gastrointestinal Hemorrhage/surgery , Humans , Pandemics , Personal Protective Equipment , Ulcer/surgeryABSTRACT
INTRODUCTION: Transverse colon cancer (TCC) is poorly studied, and TCC cases are often excluded from large prospective randomized trials because of their complexity and their potentially high complication rate. The best surgical approach for TCC has yet to be established. The aim of this large retrospective multicenter Italian series is to investigate the advantages and disadvantages of both hemicolectomy and transverse colectomy in order to identify the best surgical approach. MATERIALS AND METHODS: This was a retrospective cohort study of patients with mid-transverse colon cancer treated with a segmental colon resection or an extended hemicolectomy (right or left) between 2006 and 2016 in 28 high-volume (more than 70 procedures/year) Italian referral centers for colorectal surgery. RESULTS: The study included 1529 patients, 388 of whom underwent a segmental resection while 1141 underwent an extended resection. A higher number of complications has been reported in the segmental group than in the extended group (30.1% versus 23.6%; p 0.010). In 42 cases the main complication was the anastomotic leak (4.4% versus 2.2%; p 0.020). Recovery outcomes also showed statistical differences: time to first flatus (p 0.014), time to first mobilization (p 0.040), and overall hospital stay (p < 0.001) were significantly shorter in the extended group. Even if overall survival were similar between the groups (95.1% versus 97%; p 0.384), 3-year disease-free survival worsened after segmental resection (78.1% versus 86.2%; p 0.001). CONCLUSIONS: According to our results, an extended right colon resection for TCC seems to be surgically safer and more oncologically valid.
Subject(s)
Anastomotic Leak/epidemiology , Colectomy/methods , Colon, Transverse/surgery , Colonic Neoplasms/surgery , Length of Stay/statistics & numerical data , Surgical Wound Infection/epidemiology , Aged , Aged, 80 and over , Colon, Transverse/pathology , Colonic Neoplasms/pathology , Disease-Free Survival , Female , Humans , Italy/epidemiology , Male , Middle Aged , Neoplasm Staging , Postoperative Complications/epidemiology , Retrospective Studies , Survival Rate , Time FactorsABSTRACT
Hypoxia is a feature of most solid tumours and is associated with a poor prognosis. The hypoxic environment can reduce the efficacy of radiotherapy and some chemotherapeutics, and has been investigated extensively as a therapeutic target. The clinical use of hypoxia-targeting treatment will benefit from the development of a biomarker to assess tumour hypoxia. There are several possible techniques that measure either the level of oxygen or the tumour molecular response to hypoxia. The latter includes gene expression profiling, which measures the transcriptional response of a tumour to its hypoxic microenvironment. A systematic review identified 32 published hypoxia gene expression signatures. The methods used for their derivation varied, but are broadly classified as: (i) identifying genes with significantly higher or lower expression in cancer cells cultured under hypoxic versus normoxic conditions; (ii) using either previously characterised hypoxia-regulated genes/biomarkers to define hypoxic tumours and then identifying other genes that are over- or under-expressed in the hypoxic tumours. Both generated gene signatures useful in furthering our understanding of hypoxia biology. However, signatures derived using the second method seem to be superior in terms of providing prognostic information. Here we summarise all 32 published hypoxia signatures, discuss their commonalities and differences, and highlight their strengths and limitations. This review also highlights the importance of reproducibility and gene annotation, which must be accounted for to transfer signatures robustly for clinical application as biomarkers.
Subject(s)
Biomarkers, Tumor/metabolism , Gene Expression Profiling/methods , Neoplasms/genetics , Transcriptome/genetics , Tumor Hypoxia/genetics , Humans , PrognosisABSTRACT
Microorganisms are natural contaminants of fresh produce and minimally processed products, and contamination arises from a number of sources, including the environment, postharvest handling and processing. Fresh-cut products are particularly susceptible to microbial contaminations because of the changes occurring in the tissues during processing. In package gas composition of modified atmosphere packaging (MAP) in combination with low storage temperatures besides reducing physiological activity of packaged produce, can also delay pathogen growth. Present study investigated on the effect of MAPs, achieved with different plastic films, on microbial growth of minimally processed cactus pear (Opuntio ficus-indica) fruit. Five different plastic materials were used for packaging the manually peeled fruit. That is: a) polypropylene film (Termoplast MY 40 micron thickness, O2 transmission rate 300 cc/m2/24h); b) polyethylene film (Bolphane BHE, 11 micron thickness, O2 transmission rate 19000 cc/m2/24h); c) polypropylene laser-perforated films (Mach Packaging) with 8, 16 or 32 100-micron holes. Total aerobic psychrophilic, mesophilic microorganisms, Enterobacteriaceae, yeast, mould populations and in-package CO2, O2 and C2H4 were determined at each storage time. Different final gas compositions, ranging from 7.8 KPa to 17.1 KPa O2, and 12.7 KPa to 2.6 KPa CO2, were achieved with MY and micro perforated films, respectively. Differences were detected in the mesophilic, Enterobacteriaceae and yeast loads, while no difference was detected in psychrophilic microorganisms. At the end of storage, microbial load in fruits sealed with MY film was significantly lower than in those sealed with BHE and micro perforated films. Furthermore, fruits packed with micro-perforated films showed the highest microbial load. This occurrence may in part be related to in-package gas composition and in part to a continuous contamination of microorganisms through micro-holes.
Subject(s)
Food Packaging/methods , Fruit/chemistry , Opuntia/microbiology , Bacteria/growth & development , Food Handling , Food Packaging/instrumentation , Food Storage , Fruit/microbiology , Fungi/growth & development , Humans , Opuntia/chemistry , TasteABSTRACT
Postharvest heat treatments (hot water or hot air treatment) may be applied to horticultural crops to control fungal diseases, insect infestation and to reduce chilling injury in cultivars susceptible to low storage temperatures. The present study investigated the influence of hot water (53 degrees C for 60s) and hot air treatment (38 degrees C for 24h) applied to two typical Sardinian apple varieties, cvs. Miali and Caddina, on the composition of the lipophilic extracts of the peel as well as on the antioxidant activity of ethanolic extracts of both peel and pulp. The lipophilic extracts of the peel of the two varieties were almost similar and resulted to be dominated by the presence of triterpenes being ursolic and oleanoic acids the main metabolites in both analysed fruits. The chemical analysis of the extracts obtained from the different heat-treated samples for each variety revealed no significant difference in the relative distribution of triterpene components with respect to untreated control samples. This strongly suggested that heat treatment does not affect the composition of terpene metabolite profile of the fruit peel. On the other hand, the antioxidant activity of the ethanolic extracts of the peel and the pulp of heat treated was significantly different from that of control In particular, on Caddina variety the antioxidant activity levels of the peel were consistently higher than in the pulp and were affected by storage conditions. Differently, on Miali variety the antioxidant activity of heat-treated samples was higher than control sample in both peel and pulp.
Subject(s)
Food Preservation/methods , Malus/chemistry , Plant Extracts/analysis , Antioxidants/analysis , Fruit/chemistry , Hot Temperature , Triterpenes/analysisABSTRACT
Objective of this study was to evaluate the effect of prestorage dip treatments at 20 degrees C or 50 degrees C alone or with sodium carbonate (SC) and soy lecithin (LEC), either individually or in combination, on weight losses, peel disorders, overall appearance and decay of cactus pears. Fruits were subjected to a simulated Mediterranean fruit fly (medfly) disinfestation by cold quarantine at 2 degrees C for 21 days followed by one week of shelf-life at 20 degrees C. Hot water alone was very effective in reducing peel disorders and decay both during cold storage and shelf-life. SC applied at 20 degrees C showed a weak control of decay and chilling injury, while its effectiveness significantly increased when the solution temperature was set to 50 degrees C. LEC was more effective in preserving freshness during cold storage, but after shelf-life decay incidence in fruit dipped in LEC at 20 degrees C or 50 degrees C was higher than in those dipped in water at 20 degrees C or 50 degrees C, respectively. Significant but moderate differences were detected among treatments in weight loss. After shelf-life, fruit dipped in the heated mixture of SC and LEC showed the lowest incidence of peel disorders and the highest percentage of marketable fruit, although decay incidence was slightly higher than in fruit treated with SC at 50 degrees C. SC and LEC used in combination at 50 degrees C improved fruit tolerance to chilling injury and reduced decay.
Subject(s)
Cold Temperature , Fruit/microbiology , Lecithins/pharmacology , Opuntia/microbiology , Sodium Chloride/pharmacology , Water , Food Storage , Time FactorsABSTRACT
The objective of this study was to evaluate the effectiveness of different commercial formulations of fungicides containing one or more active ingredients in controlling postharvest decay of Thyrinthos and Boccuccia apricots, Red top peaches and Caldesi nectarines. Field treatments consisted of two sprays with cupric compounds, at the end of leaf fall and before bud swelling, one with sulfur compound, at fruit about half final size stage, and one with one of the following commercial formulations at the label suggested rates, one week before harvest: Teldor (fenexamid 50%; Bayer Crop Protection), Folicur (Tebuconazole 4.35%; Bayer Crop Protection), Signum (boscalid 26.7%, pyraclostrobin 6.7%; Basf Crop Protection), Score (difenoconazole 23.23%, Syngenta Crop Protection) and Switch (cyprodinil 37.5%, fludioxonil 25%, Syngenta Crop Protection). After harvest the fruit were stored for 1 week at 6 degrees C and 90% RH followed by 1 week at 20 degrees C and 60% RH to simulate retail conditions, or placed directly at 20 degrees C. All formulations significantly reduced decay in all cultivars. Switch, Signum and Folicur were the most active, while Score was slightly less effective. Teldor activity was low, especially in Thyrintos apricots, where the percentage of rotten fruit was slightly lower than in control fruit. Brown rot was the most representative disease, but in apricots a high percentage of fruit was affected by blue mold and grey mold. Rhizopus rot generally developed as a secondary disease on fruit previously affected by other pathogens and was more frequent in control and Teldor treated fruit. Preharvest sprays with Signum 3 days before harvest reduced postharvest decay after 1 week storage at 20 degrees C in Glo haven peaches and Venus nectarine harvested at advanced stage of maturity. Combining pre-harvest sprays with Signum and a 2-min postharvest dip in 2% sodium bicarbonate at 20 degrees C further reduced decay. In Sothern regions of Italy, the use of synthetic fungicides only immediately before harvest in years when the weather conditions are not favorable to brown rot and other pathogens inducing postharvest decay, combined with a postharvest treatment with sodium bicarbonate could be a feasible integrated approach to reduce the risk of selection of resistant strains of fungi to synthetic fungicides while controlling effectively postharvest decay.
Subject(s)
Fruit/microbiology , Fungicides, Industrial/pharmacology , Prunus/microbiology , Sodium Bicarbonate/pharmacologyABSTRACT
AIM: Anorectal dysfunction is routinely treated at the Center for Pelvic Floor Rehabilitation, San Giovanni University Hospital, Turin, Italy. Of a total of 147 patients treated between April 2007 and May 2008, 44 (30%) received pelvic floor rehabilitation following anorectal surgery. With this study we wanted to evaluate the response of patients with constipation and/or fecal incontinence to postsurgical pelvic floor rehabilitation designed to regain full or partial anorectal function and so improve their quality of life. MATERIAL AND METHODS: The study population was 44 patients, subdivided into 3 groups. One group (n=25) consisted of patients with fecal incontinence, which was further split into two subgroups: subgroup A (n=10) with direct involvement of the anal sphincter at surgery and subgroup B (n=15) without sphincter involvement. The second group (n=12) included patients with constipation. The third group (n=7) included patients with constipation and incontinence; this group was further split into 2 subgroups: those in which constipation (n=5) and those in which incontinence (n=2) was predominant. Pre- and postrehabilitation anorectal function was compared using two types of assessment: 1) clinical evaluation with the Wexner incontinence scale and 2) diagnostic evaluation with anorectal manometry in patients with fecal incontinence (plus transanal sonography to determine anatomic damage in the subgroups in which the sphincter had been involved) and defecography in those with constipation (plus transit radiography to exclude intestinal colic-associated constipation). RESULTS: The number of patients classified as having severe incontinence decreased from 8 to 1 (-87.5%), those with moderate incontinence decreased from 8 to 4 (-50%); 20 out of 25 patients presented with mild dysfunction at the end of the rehabilitation program. No difference in response to treatment was found between the two subgroups of patients with fecal incontinence nor among those with constipation. Of those with predominant constipation, none were classified as having severe dysfunction; the number of those with moderate dysfunction decreased from 13 to 7 (-54%). CONCLUSIONS: The study results show that, when sufficiently motivated, patients with fecal incontinence and constipation following anorectal surgery respond positively to pelvic floor rehabilitation.
Subject(s)
Constipation/rehabilitation , Fecal Incontinence/rehabilitation , Pelvic Floor , Rectal Diseases/complications , Rectal Diseases/surgery , Anus Diseases/complications , Anus Diseases/surgery , Biofeedback, Psychology/methods , Constipation/diagnosis , Constipation/epidemiology , Constipation/etiology , Defecography , Digestive System Surgical Procedures/adverse effects , Electric Stimulation/methods , Exercise Therapy/methods , Fecal Incontinence/diagnosis , Fecal Incontinence/epidemiology , Fecal Incontinence/etiology , Humans , Italy/epidemiology , Manometry , Prevalence , Quality of Life , Recovery of Function , Retrospective Studies , Severity of Illness Index , Treatment OutcomeABSTRACT
Adenovirus (Ad) vectors are of utility for many therapeutic applications. Strategies have been developed to alter adenoviral tropism to achieve a cell-specific gene delivery capacity employing fiber modifications allowing genetic incorporation of targeting motifs. In this regard, single chain antibodies (scFv) represent potentially useful agents to achieve targeted gene transfer. However, the distinct biosynthetic pathways that scFv and Ad capsid proteins are normally routed through have thus far been problematic with respect to scFv incorporation into the Ad capsid. Utilization of stable scFv, which also maintain correct folding and thus functionality under intracellular reducing conditions, could overcome this restriction. We genetically incorporated a stable scFv into a de-knobbed, fibritin-foldon trimerized Ad fiber and demonstrated selective targeting to the cognate epitope expressed on the membrane surface of cells. We have shown that the scFv employed in this study retains functionality and that stabilizing the targeting molecule, per se, is critical to allow retention of antigen recognition in the adenovirus capsid-incorporated context.
Subject(s)
Adenoviridae/genetics , Adenovirus Early Proteins/genetics , DNA, Single-Stranded/administration & dosage , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Immunoglobulin Variable Region/genetics , Adenoviridae/immunology , Adenovirus Early Proteins/immunology , Antigen-Antibody Reactions , Cell Line , Epitopes , Gene Expression , Gene Targeting , Genetic Engineering , Genetic Vectors/genetics , Humans , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Transduction, Genetic/methodsABSTRACT
In a recent study we have provided evidence that inhibition of native GABA(A) receptors by zinc depends primarily on the allosteric modulation of receptor gating. Both the kinetics and the sensitivity of the GABA(A) receptor to zinc depend on subunit composition, especially on the presence of the gamma(2) subunit. To analyze the mechanism of action of zinc its effects have been tested on recombinant alpha(1)beta(2)gamma(2) and alpha(1)beta(2) receptors expressed in HEK 293 cells. The currents produced by ultrafast application of GABA have been measured to assess the impact of zinc ions on GABA(A) receptor gating with resolution corresponding to the time scale of synaptic currents. While, as expected, zinc markedly reduced the peak amplitude of alpha(1)beta(2)-mediated currents, its effect on kinetics was significantly different from that observed for alpha(1)beta(2)gamma(2). In particular, unlike alpha(1)beta(2)gamma(2), zinc did not affect the onset of alpha(1)beta(2)-mediated responses. Moreover, zinc increased the extent of desensitisation of alpha(1)beta(2)gamma(2) receptors and reduced desensitisation of alpha(1)beta(2) ones. Quantitative analysis suggests that zinc exerts an allosteric modulation on both alpha(1)beta(2)gamma(2) and alpha(1)beta(2) receptors. Zinc effects on alpha(1)beta(2)gamma(2) were qualitatively similar to those reported for native receptors.
Subject(s)
Receptors, GABA-A/drug effects , Zinc/pharmacology , Algorithms , Cell Line , Electric Stimulation , Electrophysiology , Humans , Ion Channel Gating/drug effects , Kinetics , Models, Neurological , Perfusion , Protein Binding , Recombinant Proteins/drug effectsABSTRACT
OBJECTIVES: Pro-inflammatory cytokines mediate brain damage in multiple sclerosis (MS); they can also influence the hypothalamic-pituitary-adrenal (HPA) axis function. We evaluated the possible abnormalities of HPA axis function in relapsing-remitting MS (RR-MS). MATERIAL AND METHODS: IFN-gamma, TNF-alpha and IL-6 production by ex-vivo lymphocytes from 10 normal volunteers and 10 RR-MS patients before and during IFN-beta therapy was assessed; pituitary-adrenal function was evaluated by means of CRH and ACTH stimulation tests. RESULTS: In untreated patients the production of IFN-gamma, TNF-alpha, IL-6 was increased, and was significantly decreased by IFN-beta. Neither basal, nor stimulated ACTH, cortisol, DHEA, DHEAs, 17-alpha-OH-progesterone levels differed between controls and RR-MS patients, both before and during treatment. Moreover, no correlation was found between endocrine and immune parameters. CONCLUSION: In MS the HPA axis function seems normal and not influenced by IFN-beta treatment. This result is discussed in relation to the increased production of pro-inflammatory cytokines found in this disease.
Subject(s)
Adjuvants, Immunologic/therapeutic use , Hypothalamo-Hypophyseal System/metabolism , Hypothalamo-Hypophyseal System/physiopathology , Interferon-beta/therapeutic use , Interferon-gamma/metabolism , Interleukin-6/metabolism , Multiple Sclerosis , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/physiopathology , Tumor Necrosis Factor-alpha/metabolism , Adult , Female , Humans , Male , Middle Aged , Multiple Sclerosis/drug therapy , Multiple Sclerosis/metabolism , Multiple Sclerosis/physiopathologyABSTRACT
BACKGROUND: Activation of the renin-angiotensin system (RAS) may induce cardiovascular and renal fibrosis in hypertension and diabetes. This fibrogenic effect is mainly mediated by Transforming Growth Factor-B1 (TGF-B1), a multifunctional citokyne released by endothelial, vascular smooth muscle and renal mesangial cells, that is able to increase extracellular matrix deposition. Retinal capillary pericytes have functions similar to those of mesangial cells, including ability to synthesize and release TGF-B1 and produce extracellular matrix. An intraocular RAS was described in the human eye and may produce effects similar to those observed in the heart and kidney, which could be mediated by TGF-B1. In particular, TGF-B1 might be involved in thickening of the capillary basement membrane in diabetic microangiopathy. We therefore aimed at evaluating the possible effects of Angiotensin-II on TGF-B1 secretion by cultured retinal pericytes (BRP). METHODS: BRP cultures were incubated with Angiotensin-II or insulin (known to play a permissive effect on TGF-B1 release from mesangial cells) or Angiotensin-II + insulin at final concentrations of 10-10, 10-8, 10-6, 10-4 mol/L. RESULTS: Baseline TGF-B1 concentrations in the supernatants of pericyte cultures were 6 139 +/- 1 919 pg/mL/106 cells; no changes of TGF-B1 concentrations resulted from adding increasing amounts of Ang II, insulin or both. CONCLUSIONS: Though confirming that cultured bovine retinal pericytes spontaneously release TGF-B1, Angiotensin-II did not produce any stimulatory effects of in our experimental system
Subject(s)
Angiotensin II/pharmacology , Insulin/pharmacology , Pericytes/metabolism , Retina/physiology , Transforming Growth Factor beta/metabolism , Analysis of Variance , Animals , Cattle , Cells, Cultured , Pericytes/cytology , Pericytes/drug effects , Retina/drug effects , Retina/metabolism , Transforming Growth Factor beta1ABSTRACT
The intracellular expression of single-chain Fv antibody fragments (scFv) in eukaryotic cells has an enormous potential in functional genomics and therapeutics [Marasco (1997) Gene Ther. 4, 11-15; Richardson and Marasco (1995) Trends Biotechnol. 13, 306-310]. However, the application of these so-called intrabodies is currently limited by their unpredictable behavior under the reducing conditions encountered inside eukaryotic cells, which can affect their stability and solubility properties [Wörn et al. (2000) J. Biol. Chem. 275, 2795-2803; Biocca et al. (1995) Bio/Technology 13, 1110-1115]. We present a novel system that enables selection of stable and soluble intrabody frameworks in vivo without the requirement or knowledge of antigens. This system is based on the expression of single-chain antibodies fused to a selectable marker that can control gene expression and cell growth. Our results show that the activity of a selectable marker fused to well characterized scFvs [Wörn et al. (2000) J. Biol. Chem. 275, 2795-2803] correlates with the solubility and stability of the scFv moieties. This method provides a unique tool to identify stable and soluble scFv frameworks, which subsequently serve as acceptor backbones to construct intrabody complementarity determining region libraries by randomization of hypervariable loops.
Subject(s)
Complementarity Determining Regions/chemistry , DNA-Binding Proteins , Immunoglobulin Variable Region/chemistry , Recombinant Fusion Proteins/chemistry , Saccharomyces cerevisiae Proteins , Antigen-Antibody Reactions , Antigens , Cell Extracts , Cell Line , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Complementarity Determining Regions/metabolism , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/immunology , Fungal Proteins/metabolism , Genes, Reporter , Immunoglobulin Variable Region/genetics , Immunoglobulin Variable Region/immunology , Immunoglobulin Variable Region/metabolism , Leucine Zippers , Mediator Complex , Peptide Library , Protein Kinases/chemistry , Protein Kinases/immunology , Protein Kinases/metabolism , Recombinant Fusion Proteins/immunology , Saccharomyces cerevisiae/genetics , Solubility , Trans-Activators/chemistry , Trans-Activators/genetics , Transcription Factors/chemistry , Transcription Factors/metabolism , Transcriptional Activation , beta-Galactosidase/metabolismABSTRACT
Many transcription factors are multifunctional and also influence DNA replication. So far, their mechanism of action has remained elusive. Here we show that a DNA-binding protein could rely on the same biochemical activity that activates transcription to stimulate replication from the yeast chromosomal ARS1 origin. Unexpectedly, the ability to stimulate replication from this origin was not restricted to polymerase II transcription factors, but was a property shared by polymerase III factors. Furthermore, activation of replication did not depend on the process of transcription, but rather on the ability of DNA-binding transcription factors to remodel chromatin. The natural ARS1 activator Abf1 and the other transcription factors that stimulated replication remodeled chromatin in a very similar manner. Moreover, the presence of a histone H3 mutant that was previously shown to generally increase transcription also facilitated replication from ARS1 and partially compensated for the absence of a transcription factor. We propose that multifunctional transcription factors work by influencing the chromatin architecture at replication origins so as to generate a structure that is favorable to the initiation of replication.
Subject(s)
Chromatin/metabolism , DNA Replication/genetics , RNA Polymerase III/metabolism , RNA Polymerase II/metabolism , Saccharomyces cerevisiae Proteins , Transcription Factors/physiology , Binding Sites , Chromatin/genetics , Chromosomes, Fungal/genetics , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/physiology , Histones/genetics , Mutation , Protein Binding , Replication Origin/genetics , Transcription Factors/metabolism , Transcription, GeneticABSTRACT
The GAL11 gene encodes a transcription factor that is a component of the SRB/Mediator sub-complex of the RNA polymerase II holoenzyme in the yeast Saccharomyces cerevisiae. In agreement with this biochemical characterization, Gal11p has been found to be required for optimal production of mRNA from many yeast promoters, and recessive mutations in GAL11 have been shown to cause pleiotropic defects. Despite this progress, the role of Gal11p in gene regulation remains largely unknown. In a multicopy suppressor analysis of a gal11delta mutation we have identified genes encoding proteins that are part of, or can interact with, the RNA polymerase II transcription complex, as well as factors involved in cell cycle regulation. Among the suppressors that are clearly related to the transcriptional apparatus, Gal11p genetically interacts with components of the SRB/Mediator complex, as well as with factors such as TFIIE and TFIIH that are required for promoter clearance and transcription elongation by RNA polymerase II. These findings, taken together with published results of biochemical and genetic analyses, suggest a role for Galllp at the interface between the SRB/Mediator complex and the general transcription factors TFIIE and TFIIH, which modulate, via phosphorylation of the CTD, the activity of the RNA polymerase II during the transition between initiation and elongation.
Subject(s)
Cyclin-Dependent Kinases/genetics , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Promoter Regions, Genetic , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Trans-Activators/metabolism , 5' Untranslated Regions/genetics , Amino Acid Sequence , Cyclin-Dependent Kinases/chemistry , DNA, Fungal/genetics , Databases as Topic , Genomic Library , Mediator Complex , Molecular Sequence Data , Phenotype , RNA Polymerase II/genetics , RNA Polymerase II/metabolism , RNA, Messenger/genetics , Repressor Proteins/chemistry , Repressor Proteins/genetics , Saccharomyces cerevisiae/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Suppression, Genetic , Trans-Activators/geneticsABSTRACT
The RNA polymerase III-based two-hybrid system has been developed to detect interactions between proteins such as RNA polymerase II transcription factors and regulators that cannot be studied by the original RNA polymerase II two-hybrid system. This novel method appears to be most useful for a refined analysis of already known protein-protein interactions. However, the application of this system in library screenings has been impaired by the lack of a suitable assay for the selection of the activated pol III reporter gene in yeast. Here, we describe a novel selection assay for the pol III-based two-hybrid system that makes it readily usable for screening expression libraries to search for interacting partners. Our system utilizes a temperature-sensitive (ts) U6 snRNA, which is synthesized by RNA polymerase III from a mutated SNR6 gene in yeast. In this ts strain, interactions between hybrid proteins activate an artificial pol III reporter construct (UASG-SNR6), which controls expression of wild-type U6 snRNA. This wild-type U6 snRNA can suppress the ts phenotype and allow growth at the nonpermissive temperature of 37 degrees C, thus providing a positive selection system for interacting proteins.
Subject(s)
Proteins/metabolism , RNA Polymerase III/metabolism , RNA, Small Nuclear/genetics , Transcription Factors, TFII/metabolism , Transcription Factors/metabolism , Animals , Genes, Reporter , Mice , Transcription Factor TFIIA , Transcription Factor TFIID , Yeasts/geneticsABSTRACT
Several eukaryotic transcription factors such as Sp1 or Oct1 contain glutamine-rich domains that mediate transcriptional activation. In human cells, promoter-proximally bound glutamine-rich activation domains activate transcription poorly in the absence of acidic type activators bound at distal enhancers, but synergistically stimulate transcription with these remote activators. Glutamine-rich activation domains were previously reported to also function in the fission yeast Schizosaccharomyces pombe but not in the budding yeast Saccharomyces cerevisiae, suggesting that budding yeast lacks this pathway of transcriptional activation. The strong interaction of an Sp1 glutamine-rich domain with the general transcription factor TAF(II)110 (TAF(II)130), and the absence of any obvious TAF(II)110 homologue in the budding yeast genome, seemed to confirm this notion. We reinvestigated the phenomenon by reconstituting in the budding yeast an enhancer-promoter architecture that is prevalent in higher eukaryotes but less common in yeast. Under these conditions, we observed that glutamine-rich activation domains derived from both mammalian and yeast transcription factors activated only poorly on their own but strongly synergized with acidic activators bound at the remote enhancer position. The level of activation by the glutamine-rich activation domains of Sp1 and Oct1 in combination with a remote enhancer was similar in yeast and human cells. We also found that mutations in a glutamine-rich domain had similar phenotypes in budding yeast and human cells. Our results show that glutamine-rich activation domains behave very similarly in yeast and mammals and that their activity in budding yeast does not depend on the presence of a TAF(II)110 homologue.
Subject(s)
DNA-Binding Proteins/genetics , Sp1 Transcription Factor/genetics , Transcription Factors/genetics , Transcriptional Activation , Amino Acid Sequence , Conserved Sequence , Evolution, Molecular , Glutamine , Host Cell Factor C1 , Humans , Molecular Sequence Data , Octamer Transcription Factor-1 , Saccharomyces cerevisiae/geneticsABSTRACT
Zinc is abundantly present in the CNS, and after nerve stimulation is thought to be released in sufficient quantity to modulate the synaptic transmission. Although it is known that this divalent cation inhibits the GABAergic synaptic currents, the underlying mechanisms were not fully elucidated. Here we report that zinc reduced the amplitude, slowed the rise time, and accelerated the decay of mIPSCs in cultured hippocampal neurons. The analysis of current responses to rapid GABA applications and model simulations indicated that these effects on mIPSCs are caused by zinc modulation of GABA(A) receptor gating. In particular, zinc slowed the onset of GABA-evoked currents by decreasing both the binding (k(on)) and the transition rate from closed to open state (beta(2)). Moreover, slower onset and recovery from desensitization as well as an increased unbinding rate (k(off)) were shown to underlie the accelerated deactivation kinetics in the presence of zinc. The nonequilibrium conditions of GABA(A) receptor activation were found to strongly affect zinc modulation of this receptor. In particular, an extremely fast clearance of synaptic GABA is implicated to be responsible for a stronger zinc effect on mIPSCs than on current responses to exogenous GABA. Finally, the analysis of currents evoked by GABA coapplied with zinc indicated that the interaction between zinc and GABA(A) receptors was too slow to explain zinc effects in terms of competitive antagonism. In conclusion, our results provide evidence that inhibition of mIPSCs by zinc is attributable to the allosteric modulation of GABA(A) receptor gating.
Subject(s)
Allosteric Regulation/physiology , Ion Channel Gating/physiology , Neurons/metabolism , Receptors, GABA-A/metabolism , Zinc/metabolism , Allosteric Regulation/drug effects , Animals , Binding, Competitive/drug effects , Cells, Cultured , Computer Simulation , Dose-Response Relationship, Drug , Evoked Potentials/drug effects , GABA Antagonists/pharmacology , Hippocampus/cytology , Hippocampus/drug effects , Hippocampus/metabolism , Ion Channel Gating/drug effects , Membrane Potentials/drug effects , Models, Neurological , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/cytology , Neurons/drug effects , Patch-Clamp Techniques , Protein Conformation/drug effects , Rats , Rats, Wistar , Receptors, GABA-A/drug effects , Sodium Channel Blockers , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Zinc/pharmacology , beta-Alanine/pharmacology , gamma-Aminobutyric Acid/metabolism , gamma-Aminobutyric Acid/pharmacologyABSTRACT
A cellular assay system for measuring the activity of cytoplasmically expressed anti-GCN4 scFv fragments directed against the Gcn4p dimerization domain was established in the budding yeast Saccharomyces cerevisiae. The inhibitory potential of different constitutively expressed anti-GCN4 scFv intrabodies was monitored by measuring the activity of beta-galactosidase expressed from a GCN4-dependent reporter gene. The in vivo performance of these scFv intrabodies in specifically decreasing reporter gene activity was related to their in vitro stability, measured by denaturant-induced equilibrium unfolding. A framework-engineered stabilized version showed significantly improved activity, while a destabilized point mutant of the anti-GCN4 wild-type showed decreased effects in vivo. These results indicate that stability engineering can result in improved performance of scFv fragments as intrabodies. Increasing the thermodynamic stability appears to be an essential factor for improving the yield of functional scFv in the reducing environment of the cytoplasm, where the conserved intradomain disulfides of antibody fragments cannot form.